2015, Number 3
<< Back Next >>
Rev Cubana Cardiol Cir Cardiovasc 2015; 21 (3)
Ventricular Cardiomyopathy not compact. About his association with other extracardiac entities, alter-native therapeutic and prognostic factors
Jerez CAM, Echevarría PS, Guevara MG, Aleaga CE, González TA
Language: Spanish
References: 18
Page:
PDF size: 162.83 Kb.
ABSTRACT
Hypertrabeculation/non-compaction of the left ventricle (LVHT) is associated, in most cases, a disease of the heart or skeletal hereditary chromosomal abnormalities or muscle. Depending on the study, more than two thirds of patients with LVHT also have a neuromuscular disease (NMD). The NMD LVHT associated with most frequently are the Barth syndrome, mitochondrial diseases, zaspopatía, and myotonic dystrophy. The NMD that are only present with LVHT are occasionally distrobrevinopatía, laminopathies, dystrophinopathies, miodelinato of deaminase deficiency, hereditary inclusion body myositis, and CMT1A neuropathy. A causal relationship between NMD and LVHT is likely, but the exact relationship and partnership pathomechanics remain elusive. The nearby pathogenic relationship is supported by the fact that the phenomenon of acquired LVHT occurs predominantly in the NMD. A consistent referral of patients with LVHT the neurologist, the subsequent referral of patients with NMD cardiologist, and family research can help clarify matters still unresolved concerning the pathogenesis, course and prognosis of LVHT.
REFERENCES
Weiford BC, Subbarao VD, Mulhern KM. Noncompaction of theventricular myocardium. Circulation 2004; 109:2965-71.
Stöllberger C, Finsterer J, Blazek G, Bittner RE. Left ventri-cularnon-compaction in a patient with becker's muscular dy-strophy.Heart 1996; 76: 380.
Oechslin, E.N., AttenhoferJost, C.H., Rojas, J.R., et al., Long-term follow-up of 34 adults with isolated left ventricu-lar noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol, 2000. 36(2): p. 493-500.
Lofiego, C., Biagini, E., Pasquale, F., et al., Wide spectrum of presentation and variable outcomes of isolated left ven-tricular non-compaction. Heart, 2007. 93(1): p. 65-71.
McMahon, C.J., Pignatelli, R.H., Nagueh, S.F., et al., Left ventricular non-compaction cardiomyopathy in children: characterisation of clinical status using tissue Doppler-derived indices of left ventricular diastolic relaxation. Heart, 2007. 93(6): p. 676-81.
Nucifora, G., Aquaro, G.D., Pingitore, A., et al., Myocardial fibrosis in isolated left ventricular non-compaction and its re-lation to disease severity. Eur J Heart Fail, 2011. 13(2): p. 170-6.
Néstor O. Galizio, José l. González, Liliana E. Favaloro, Mir-ta Diez. Miocardiopatía no compactada. Estratificación de riesgo de muerte súbita para indicación de cardiodesfibrila-dor automático implantable. Revista argentina de cardiología versión ISSN 1850-3748. Cardiol. vol.79 no.1 Ciudad Autó-noma de Buenos Aires ene./feb. 2011
Bleyl SB, Mumford BR, Thompson V, et al. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J HumGenet 1997; 61: 868-72.
Finsterer J, Stöllberger C. Hypertrabeculated left ventricle in mito- chondriopathy. Heart 1998; 80: 632.
Ichida F, Tsubata S, Bowles KR, et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syn-drome.Circulation 2001; 103: 1256-63.
Finsterer J, Stöllberger C, Wegmann R, Jarius C, Janssen B. Left ventricular hypertrabeculation in myotonic dystrophy type 1. Herz2001; 26: 287-90.
Vatta M, Mohapatra B, Jimenez S, et al. Mutations in cypher/ZASP in patients with dilated cardiomyopathy and left ven-tricular non-compaction. J Am Coll Cardiol 2003; 42: 2014-27.
Hermida-Prieto M, Monserrat L, Castro-Beiras A, et al. Fa-milial dilated cardiomyopathy and isolated left ventricular noncompactionassociated with lamin A/C gene mutations. Am J Cardiol 2004; 94:50-4.
Finsterer J, Gelpi E, Stöllberger C. Left ventricular hypertra-beculation / noncompaction as a cardiac manifestation of Du-chenne muscular dystrophy under non-invasive positive-pressure ventilation. Acta Cardiol 2005; 60: 445-8.
Finsterer J, Schoser B, Stöllberger C. Myoadenylate-deaminasegene mutation associated with left ventricular hypertrabeculation/non-compaction. Acta Cardiol 2004; 59: 453-6.
Corrado G, Checcarelli N, Santarone M, Stollberger C, Fin-sterer J.Left ventricular hypertrabeculation/noncompaction with PMP22duplication-based Charcot-Marie-Tooth disease type 1A. Cardiology 2006; 105: 142-5.
Wahbi K, Meune C, Bassez G, et al. Left ventricular-noncompaction in a patient with myotonic dystrophy type 2. NeuromusculDisord 2008; 18: 331-3.
Finsterer J, Stöllberger C, Höftberger R. Left ventricular hy-pertrabeculation / noncompaction in hereditary inclusion body myopathy.Int J Cardiol 2009; (in press).